A retrospective, multicenter study of efficacy of pembrolizumab in patients with metastatic urothelial carcinoma
Latest Information Update: 24 Aug 2022
At a glance
- Drugs Pembrolizumab (Primary) ; Antineoplastics
- Indications Carcinoma; Urogenital cancer
- Focus Therapeutic Use
Most Recent Events
- 04 Jul 2022 Results presented at the 37th Congress of the European Association of Urology
- 30 Dec 2021 New trial record
- 01 Dec 2021 Results published in the International Journal of Urology